Evidence map›Paper›PMID 35027574›Full record

ArticleNPJ genomic medicine2022

Evidence that the Ser192Tyr/Arg402Gln in cis Tyrosinase gene haplotype is a disease-causing allele in oculocutaneous albinism type 1B (OCA1B).

Siying Lin, Aida Sanchez-Bretaño, Joseph S Leslie, Katie B Williams, Helena Lee, N Simon Thomas, Jonathan Callaway, James Deline, J Arjuna Ratnayaka, Diana Baralle and 10 more

Open access · goldAbstract read
In one paragraph

Article in NPJ genomic medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

Siying LinRILD Wellcome Wolfson Centre, Royal Devon & Exeter NHS Foundation Trust, Barrack Road, Exeter, UK.ORCID http://orcid.org/0000-0003-1122-8396
Aida Sanchez-BretañoClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Joseph S LeslieRILD Wellcome Wolfson Centre, Royal Devon & Exeter NHS Foundation Trust, Barrack Road, Exeter, UK.
Katie B WilliamsCenter for Special Children, Vernon Memorial Healthcare, La Farge, WI, USA.
Helena LeeClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
N Simon ThomasFaculty of Medicine, University of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0002-1494-2467
Jonathan CallawayFaculty of Medicine, University of Southampton, Southampton, UK.
James DelineCenter for Special Children, Vernon Memorial Healthcare, La Farge, WI, USA.
J Arjuna RatnayakaClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Diana BaralleHuman Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0003-3217-4833
Melanie A SchmittUniversity of Wisconsin School of Medicine and Public Health, Department of Ophthalmology & Visual Sciences, Madison, WI, USA.
Chelsea S NormanClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0001-5698-1651
Sheri HammondCenter for Special Children, Vernon Memorial Healthcare, La Farge, WI, USA.
Gaurav V HarlalkaRILD Wellcome Wolfson Centre, Royal Devon & Exeter NHS Foundation Trust, Barrack Road, Exeter, UK.ORCID http://orcid.org/0000-0001-8968-2447
Sarah EnnisDepartment of Human Genetics and Genomic Medicine, University of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0003-2648-0869
Harold E CrossDepartment of Ophthalmology, University of Arizona College of Medicine, Tucson, AZ, USA.
Olivia WengerNew Leaf Clinic, PO Box 336, 16014 East Chestnut Street, Mount Eaton, OH, 44691, USA.
Andrew H CrosbyRILD Wellcome Wolfson Centre, Royal Devon & Exeter NHS Foundation Trust, Barrack Road, Exeter, UK. a.h.crosby@exeter.ac.uk.
Emma L BapleRILD Wellcome Wolfson Centre, Royal Devon & Exeter NHS Foundation Trust, Barrack Road, Exeter, UK. E.Baple@exeter.ac.uk.ORCID http://orcid.org/0000-0002-6637-3411
Jay E SelfClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. jes3@soton.ac.uk.ORCID http://orcid.org/0000-0002-1030-9963
Royal Devon & Exeter NHS Foundation Trust · GBUniversity of Southampton · GBSalisbury District Hospital · GBUniversity Hospital Southampton NHS Foundation Trust · GBChestnut Hill College · USRosalind Franklin Institute · GBUniversity of Arizona · US

Funding

Medical Research Council G0501759RCUK | Medical Research Council (MRC) G1001931RCUK | Medical Research Council (MRC) G1002279RCUK | Medical Research Council (MRC) MC_PC_15047RCUK | Medical Research Council (MRC) MC_PC_15054RCUK | Medical Research Council (MRC) MC_PC_18047University of Exeter Vice Chancellor Scholarship
6 · The paper itself

Abstract

Oculocutaneous albinism type 1 (OCA1) is caused by pathogenic variants in the TYR (tyrosinase) gene which encodes the critical and rate-limiting enzyme in melanin synthesis. It is the most common OCA subtype found in Caucasians, accounting for ~50% of cases worldwide. The apparent 'missing heritability' in OCA is well described, with ~25-30% of clinically diagnosed individuals lacking two clearly pathogenic variants. Here we undertook empowered genetic studies in an extensive multigenerational Amish family, alongside a review of previously published literature, a retrospective analysis of in-house datasets, and tyrosinase activity studies. Together this provides irrefutable evidence of the pathogenicity of two common TYR variants, p.(Ser192Tyr) and p.(Arg402Gln) when inherited in cis alongside a pathogenic TYR variant in trans. We also show that homozygosity for the p.(Ser192Tyr)/p.(Arg402Gln) TYR haplotype results in a very mild, but fully penetrant, albinism phenotype. Together these data underscore the importance of including the TYR p.(Ser192Tyr)/p.(Arg402Gln) in cis haplotype as a pathogenic allele causative of OCA, which would likely increase molecular diagnoses in this missing heritability albinism cohort by 25-50%.

Identifiers

PMID35027574
PMCPMC8758782
OpenAlexW4205197622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.